KR900701795A - 티에노시클로 헵타피리다진 화합물과 그것의 의약용도 - Google Patents

티에노시클로 헵타피리다진 화합물과 그것의 의약용도

Info

Publication number
KR900701795A
KR900701795A KR1019900701038A KR900701038A KR900701795A KR 900701795 A KR900701795 A KR 900701795A KR 1019900701038 A KR1019900701038 A KR 1019900701038A KR 900701038 A KR900701038 A KR 900701038A KR 900701795 A KR900701795 A KR 900701795A
Authority
KR
South Korea
Prior art keywords
thieno
cyclohepta
pyridazin
tetrahydro
compound
Prior art date
Application number
KR1019900701038A
Other languages
English (en)
Other versions
KR920007437B1 (ko
Inventor
토루 나카오
히로시 다나카
야츠토 모리모토
수조 다케하라
Original Assignee
하기하라 다게미오
요시토미 세이야쿠 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하기하라 다게미오, 요시토미 세이야쿠 가부시기가이샤 filed Critical 하기하라 다게미오
Publication of KR900701795A publication Critical patent/KR900701795A/ko
Application granted granted Critical
Publication of KR920007437B1 publication Critical patent/KR920007437B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

내용 없음

Description

티에노시클로 헵타피리다진 화합물과 그것의 의약용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기 일반식의 티에노시클로헵타 피리다진 화합물.
    상기식에서, R은 수소, 할로겐 또는 C1-4아킬이고, Ar은 아릴, 헤테로아릴, 또는 치환기로 할로겐, C1-4알킬, C1-4알콕시, 니트로, 아미노, 히드록시, 트리플루오로메틸 및/또는 C2-5알카노일-아미노를 적어도 하나 갖는 아릴 또는 헤테로 아릴이며, 6a위치와 7위치 간의 결합 ………은 단일 결합 또는 이중결합이다.
  2. 제1항에 있어서, 9-(4-클로로페닐)-2-메틸 5,6,6a,7-테트라히드로 -4H-티에노〔2,3,-f〕시클로헵타〔1,2-c〕피리다진-8(9H)-온, 9-페닐-2-메틸 5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕시클로헵타〔1,2-c〕피리다진-8(9H)-온, 9-(4-메틸페)-2-메틸 5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(4-메톡시 페닐)-2-메틸-5,6,6a,7-테드라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(4-클로로 페닐)-5,6-디히드로-2-메틸-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(4-클로로 페닐)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(6-클로로-2-피리딜)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(4-메틸페닐)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 9-(4-메톡시페닐)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 2-브로모-9-(4-클로로페닐)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕 피리다진-8(9H)-온, 2-브로모-9-(4-클로로페닐)-5,6,6a,7-테트라히드로-4H-티에노〔2,3-f〕 시클로헵타 〔1,2-c〕피리다진-8(9H)-온, 및 2-브로모-9-(4-클로로페닐)-5,6-디히드로-4H-티에노〔2,3-f〕 시클로헵타〔1,2-c〕 피리다진-8(9H)-온, 등의 그룹중에서 선택된 화합물.
  3. 제1항 또는 제2항의 화합물과 의약용 첨가제를 함유한 의약 조성물.
  4. 제1항 또는 제2항의 화합물을 유효성분으로 함유한 항 불안제.
  5. 제1항 또는 제2항의 화합물을 유효성분으로 함유한 건망증 치료제, 뇌기능 활성제 또는 항치매제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900701038A 1988-09-21 1989-09-20 티에노시클로 헵타 피리다진 화합물과 그것의 의약용도 KR920007437B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP237600 1988-09-21
JP23760088 1988-09-21
JP237600/88 1988-09-21
PCT/JP1989/000956 WO1990003380A1 (en) 1988-09-21 1989-09-20 Thienocycloheptapyridazine compounds and medicinal uses thereof

Publications (2)

Publication Number Publication Date
KR900701795A true KR900701795A (ko) 1990-12-04
KR920007437B1 KR920007437B1 (ko) 1992-09-01

Family

ID=17017723

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701038A KR920007437B1 (ko) 1988-09-21 1989-09-20 티에노시클로 헵타 피리다진 화합물과 그것의 의약용도

Country Status (4)

Country Link
US (1) US5153194A (ko)
EP (1) EP0394471A4 (ko)
KR (1) KR920007437B1 (ko)
WO (1) WO1990003380A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2028496A1 (en) * 1989-10-31 1991-05-01 Tohru Nakao Thiophene compounds and their pharmaceutical uses
US5597918A (en) * 1991-08-27 1997-01-28 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyridazine compound
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3631174A (en) * 1970-01-06 1971-12-28 American Cyanamid Co 4 5-heterocyclic substituted-6 7-dihydrobenzothiophenes
US3816437A (en) * 1972-12-22 1974-06-11 Sandoz Ag Thieno(2,3-g)indazoles
US4602019A (en) * 1983-04-22 1986-07-22 Warner-Lambert Company Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents
GB2164643B (en) * 1984-07-27 1988-11-02 Boehringer Biochemia Srl Tricyclic dihydropyridazinones and pharmaceutical compositions containing them
JPH06763B2 (ja) * 1984-08-28 1994-01-05 吉富製薬株式会社 ベンゾ〔ｈ〕シンノリン誘導体
AU578496B2 (en) * 1984-11-01 1988-10-27 Smith Kline & French Laboratories Limited Tricyclic heterocyclic compounds
JPH0633277B2 (ja) * 1986-01-10 1994-05-02 吉富製薬株式会社 ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物
DE3867086D1 (de) * 1987-03-02 1992-02-06 Yoshitomi Pharmaceutical Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
JP2615785B2 (ja) * 1987-03-25 1997-06-04 吉富製薬株式会社 チエノシンノリン化合物
WO1988007533A1 (en) * 1987-03-25 1988-10-06 Yoshitomi Pharmaceutical Industries, Ltd. Thienocinnoline compounds and their medicinal application
US5032216A (en) * 1989-10-20 1991-07-16 E. I. Du Pont De Nemours And Company Non-photographic method for patterning organic polymer films

Also Published As

Publication number Publication date
KR920007437B1 (ko) 1992-09-01
WO1990003380A1 (en) 1990-04-05
US5153194A (en) 1992-10-06
EP0394471A1 (en) 1990-10-31
EP0394471A4 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
ES2060910T3 (es) Peptidos que tienen actividad antagonista de taquiquinina, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
KR910011896A (ko) 신규한 글리코펩티드 유도체
IL59084A0 (en) (piperidinylalkyl)quinazoline derivatives,their preparation and pharmaceutical compositons containing them
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
KR870003974A (ko) 비시클로 치환된 페닐아세토니트릴 유도체
KR960010635A (ko) 약제학적 화합물
KR920703512A (ko) 단백질 활성효소 c(protein kinase c)를 방해하는 1, 4-비스-(아미노-하이드록시알킬아미노)-안트라퀴논
KR900701795A (ko) 티에노시클로 헵타피리다진 화합물과 그것의 의약용도
KR960007592A (ko) 신규한 피롤로카바졸
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
KR910004191A (ko) 신질환치료제
KR890014107A (ko) 백금 화학 요법약제
AU2983792A (en) Diaminomethyleneamino substituted substituted phenyl thiazoles
KR910005860A (ko) 항간질환성 조성물
KR890012973A (ko) 이미다졸 유도체
KR890700584A (ko) 헤테로아릴카르복시아미드 유도체 그의 제조방법 및 그것을 함유하는 의약조성물
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
KR890003372A (ko) 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR890003718A (ko) N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제
KR910006217A (ko) 디히드로카페인산 유도체 및 이를 함유하는 약학제제
DK105183A (da) Fremgangsmaade til fremstilling af 1,4-diaminocyclitolderivater
KR890006592A (ko) 생리활성을 가진 피라졸 유도체 및 그 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee